Fiasp Penfill Injection 100 IU 3ml is used to treat diabetes mellitus. However, the uses mentioned here are not exhaustive. There may be other conditions for which this medication may be used upon a doctor’s discretion.
The active ingredient of Fiasp Penfill Injection 100 IU 3ml is Insulin Aspart 100 IU.
Insulin Aspart acts by reducing the blood sugar levels and this drug starts working within 15min after injection and shows its effect for 2 to 4 hours. Thus how improves blood sugar control in people with Diabetes Mellitus.
Patients with the following conditions are suggested to seek advice from their health care professionals before taking the Fiasp Penfill Injection 100 IU 3ml:
The following side effects may or may not occur during the usage of this Fiasp Penfill Injection 100 IU 3ml. It is generally well tolerated when taken in the prescribed dosage guidelines. More common ones are generally mild and may include:
Rare but more serious adverse effects may include:
Fiasp Penfill Injection 100 IU 3ml injection is a cartridge that is used along with a pen.
It is a refill that is replaced in a pen once the cartridge or pen fill becomes empty.
The procedure for injecting the insulin is as prescribed by your doctor or follow the instructions given on the label.
Avoid using more than the prescribed dosage. In case of an accidental overdose, look for any new symptoms. If you observe any, promptly seek medical advice or report it to the nearby poison control center.
Take the Fiasp Penfill Injection 100 IU 3ml only on the advice of a medical practitioner. Dosage adjustment or complete avoidance of the medication may be required in the following conditions:
Caution advised among people with renal problems. If you have any, consult your doctor before using this Fiasp Penfill Injection 100 IU 3ml.
Caution advised among people with hepatic problems. If you have any, consult your doctor before using this Fiasp Penfill Injection 100 IU 3ml.
May be used during pregnancy. However, use the medicine only if suggested by your physician.
May be used during breastfeeding. Risk of infant harm not expected based on human data and drug properties. However, there are chances of delayed milk production based on conflicting human data.
Caution always advised when used with other medicines. Therefore, inform your doctor about your current list of medicine(s) (if any) during the treatment.
Category B:Â Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Insulin Preparations
ABBOTT
abbott india ltd,3-4 corporarte park,sion-trombay road,mumbai-400071
ABBOTT
abbott india ltd,3-4 corporarte park,sion-trombay road,mumbai-400071